Updated January 18th, 2023
Last year we caught word that a new hyaluronic acid filler was being tested in the U.S. in the lower face to provide more definition, and today Allergan Aesthetics, an AbbVie company, announced that the FDA-approved Juvéderm Volux jawline filler is now available nationwide.
Beverly Hills, CA dermatologist Ava Shamban, MD, first told us that a filler for lower face reshaping and contouring was on its way all the way back in January of last year: “There is a product being used in Europe called Juvéderm Volux that is in trials here in the United States for use on the jawline,” she noted. In August, the FDA approved it for use along the jawline, making it the first HA filler approved for this area.
Jawline filler is sometimes combined with neurotoxin injections to create a slimming effect in the lower face—has been performed off-label for years, however, Volux is the first product that gets the FDA’s stamp of approval for the jawline.
“Many different types of patients can benefit from Volux whether you want to address the appearance of jowls or the contour of the jawline,” said New York plastic surgeon Sachin Shridharani, MD in AbbVie’s press release. “With the addition of this new dermal filler to the Juvéderm collection, I can create a smooth, natural-looking, and long-lasting contour that lasts up to twelve months with optimal treatment.”
“It’s certainly a welcome addition to Juvéderm’s line of hyaluronic acid products,” says West Palm Beach, FL dermatologist Kenneth Beer, MD. “It’s thick enough that it can sculpt the jaw without looking jowly. It’s great for patients that have lost definition in the lower face and have that sort of have that hound-dog look that occurs as you start to age. This is going to help reshape the jaw into something more youthful and defined.”
“Having a strong jawline is the crux of maintaining a youthful neck not to mention a feminine yet powerful face,” adds Dr. Shamban. “With Volux we have one more product that fits the bill.”
Delray Beach, FL practice dermatologist Dr. Janet Allenby shares that it’s a welcome addition to her dermal filler toolbox and her patients are eager to use it. “It was launched in Europe in 2019 and we hear from our colleagues abroad that it is a fantastic option for the jawline, it’s actually a stiffer filler, and we really haven’t had anything like this in our hyaluronic acid line. Because it has the backing of Allergen we know that they are a prestigious company with great products and this is just as good as the other dermal fillers we use every day. We’re all very excited to have it available now.”
